Ursprung des Netzwerks ersten Grades von George Adams
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
University of Toronto Innovations Foundation
 University of Toronto Innovations Foundation Miscellaneous Commercial ServicesCommercial Services University of Toronto Innovations Foundation provides research, technology, and educational services. It assists the university and its research ancillaries to apply and commercialize the knowledge, innovations, and inventions generated through discovery research. It also manages The Exceler@tor, an incubator for growing technology companies. The firm was founded in 1980 and is headquartered in Toronto, Canada.
1
| Extinct | Miscellaneous Commercial Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von George Adams
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| SERNOVA CORP. | Biotechnology | Chairman | |
Baxter Corp.
 Baxter Corp. Medical SpecialtiesHealth Technology Baxter Corp. supplies health care and laboratory products. Its products are used for treating cancer, hemophilia, immune deficiencies, kidney disease, and trauma. The company is headquartered in Mississauga, Canada | Medical Specialties | Corporate Officer/Principal | |
| CELL MEDX CORP. | Medical Specialties | Chairman | |
| BOSTON SCIENTIFIC CORPORATION | Medical Specialties | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Corvita Corp.
 Corvita Corp. Medical SpecialtiesHealth Technology Corvita Corporation is a development stage company engaged primarily in research and development of new medical devices and related biomaterials for treatment of late stage vascular disease. The company is sponsoring two FDA controlled, randomized prospective trials in the US for its peripheral grafts and AV access grafts, both of which are approved for sale in the European Common Market. In addition, Corvita is conducting clinical tests in Europe and plans to begin FDA controlled clinical studies in the US of the Corvita Endoluminal Graft, a new less invasive product for lower cost treatment of vascular trauma, vascular occlusive disease and aneurysmal disease. The majority of the company's activities in FY 96 will be focused on development and testing of Corvita Endoluminal Grafts. | Medical Specialties | Corporate Officer/Principal | |
| E I DU PONT DE NEMOURS AND CO | Chemicals: Agricultural | Corporate Officer/Principal | |
World Heart Corp.
 World Heart Corp. Miscellaneous Commercial ServicesCommercial Services World Heart Corp. develops artificial heart and related technologies. The company was founded on April 1, 1996 and is headquartered in Salt Lake City, UT. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| VENTRIPOINT DIAGNOSTICS LTD. | Medical Specialties | Chairman | |
| McMaster University | College/University | Doctorate Degree | |
The Canadian Red Cross Society
 The Canadian Red Cross Society Miscellaneous Commercial ServicesCommercial Services The Canadian Red Cross Society offers courses in first aid, CPR, and swimming and water safety. The organization is based in Mississauga, Canada. The Canadian company also provides various services to migrants and refugees upon their arrival. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The University of Ottawa Heart Institute
 The University of Ottawa Heart Institute Hospital/Nursing ManagementHealth Services The University of Ottawa Heart Institute operates as a health center to understand, treat, and prevent heart disease. The firm's clinical departments include clinical care, cardiology, cardiac imaging, cardiac surgery, cardiac anesthesiology, cardiac prevention and rehabilitation, clinical services, biomedical engineering and diagnostic services. The company was founded in 1976 and is headquartered in Ottawa, Canada. | Hospital/Nursing Management | Director/Board Member | |
| PROMIS NEUROSCIENCES, INC. | Biotechnology | Chief Executive Officer | |
| Hemo-Stat Ltd. | President | ||
| Canadian Biomaterials Society | President | ||
| The University of Waterloo | College/University | Graduate Degree | |
Cell MedX (Canada) Corp.
 Cell MedX (Canada) Corp. Pharmaceuticals: MajorHealth Technology Part of Cell MedX Corp., Cell MedX (Canada) Corp. is a Canadian pharmaceutical company. The company is based in Vancouver, Canada. The CEO of the company is Frank E. Mcenulty. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Kanada | 13 |
| Vereinigte Staaten | 6 |
Sektoral
| Health Technology | 10 |
| Commercial Services | 3 |
| Consumer Services | 3 |
| Process Industries | 2 |
| Health Services | 2 |
Operativ
| Corporate Officer/Principal | 8 |
| Director/Board Member | 6 |
| President | 6 |
| Chairman | 3 |
| Chief Executive Officer | 3 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| George Adams | 18 |
- Börse
- Insiders
- George Adams
- Unternehmensverbindungen
